
In order to determine the efficacy of a novel zzso zzso suspension, we performed two prospective sequential zzso studies in patients with pain due to zzso The studies were identical except for the duration of treatment (three days and 30 days zzso zzso patients with a variety of advanced zzso and associated pain zzso zzso patients completed the trials, 38 on the three-day trial and 15 on the 30-day zzso In both groups the amount of zzso required to obtain pain relief was initially established using zzso zzso zzso and zzso zzso for zzso zzso Patients were begun on equivalent doses of the study drug in place of the zzso zzso No differences in pain score or the amount of zzso zzso were noted following the switch to the zzso zzso zzso zzso was as anticipated for the use of zzso in this situation and no adverse effects were observed during administration of the zzso These data suggest that this new zzso of zzso is zzso to conventional zzso zzso zzso and provides pain relief for a 12-hour dosing zzso This novel zzso zzso could be especially useful for zzso patients and for those who have difficulty in zzso 

